Dr. Erlyani Hamid’s career spans science and academia to strategic corporate leadership in global health. Trained as a stem-cell biologist, she made significant contributions in pioneering cutting-edge techniques like high-throughput single-cell transcriptomics, collaborating with University of Cambridge and working at the Genome Institute of Singapore.

Her journey towards broader impact in global health led her to Hilleman Labs where she now plays a central role in shaping the strategic outlook for the company, developing affordable vaccines for low- and middle-income countries to improve public health outcomes. She also leads strategic initiatives in partnership with charitable foundations and NGOs, working to catalyse positive change in global health.

Dr Hamid is a proud champion of women’s leadership and role in science and global health, having previously co-founded a diversity workgroup around empowering women in STEM and driving dialogues with women leaders in global health.

Dr. Hamid is committed to advancing global health initiatives and improving the lives of millions around the world.